Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification

Triple negative breast cancer (TNBC) is a subtype of breast cancer with complex heterogeneity, high invasiveness, and long-term poor prognosis. With the development of molecular pathology and molecular genetics, the gene map of TNBC with distinctive biological characteristics has been outlined more...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yubao Zhang, Xiaoran Ma, Huayao Li, Jing Zhuang, Fubin Feng, Lijuan Liu, Cun Liu, Changgang Sun
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/960a9398b2444583b15a023c2eb9e77d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:960a9398b2444583b15a023c2eb9e77d
record_format dspace
spelling oai:doaj.org-article:960a9398b2444583b15a023c2eb9e77d2021-11-11T05:52:51ZIdentifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification1663-981210.3389/fphar.2021.685773https://doaj.org/article/960a9398b2444583b15a023c2eb9e77d2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.685773/fullhttps://doaj.org/toc/1663-9812Triple negative breast cancer (TNBC) is a subtype of breast cancer with complex heterogeneity, high invasiveness, and long-term poor prognosis. With the development of molecular pathology and molecular genetics, the gene map of TNBC with distinctive biological characteristics has been outlined more clearly. Natural plant extracts such as paclitaxel, vinblastine, colchicine etc., have occupied an important position in the treatment of hormone-independent breast cancer. Ursolic acid (UA), a triterpenoid acid compound derived from apple, pear, loquat leaves, etc., has been reported to be effective in a variety of cancer treatments, but there are few reports on the treatment of TNBC. This study performed comprehensive bioinformatics analysis and in vitro experiments to identify the effect of UA on TNBC treatment and its potential molecular mechanism. Our results showed that UA could not only reduce the proliferation, migration, and invasion in MDA-MB-231 and MDA-MB-468 cell lines with a dose-dependent manner but also induce cell cycle arrest and apoptosis. Meanwhile, we collected the gene expression data GSE45827 and GSE65194 from GEO for comparison between TNBC and normal cell type and obtained 724 DEGs. Subsequently, PLK1 and CCNB1 related to TNBC were screened as the key targets via topological analysis and molecular docking, and gene set enrichment analysis identified the key pathway as the p53 signaling pathway. In addition, quantitative real-time PCR and western blot verified the key genes were PLK1 and CCNB1. In vivo and in vitro experiments showed that UA could inhibit the growth of TNBC cells, and down-regulate the protein expression levels of PLK1 and CCNB1 by mediating p53 signaling pathway. These findings provide strong evidence for UA intervention in TNBC via multi-target therapy.Yubao ZhangXiaoran MaHuayao LiJing ZhuangFubin FengLijuan LiuCun LiuChanggang SunChanggang SunFrontiers Media S.A.articleursolic acidtriple-negative breast cancerantiproliferativenetwork pharmacologymolecular dockingTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic ursolic acid
triple-negative breast cancer
antiproliferative
network pharmacology
molecular docking
Therapeutics. Pharmacology
RM1-950
spellingShingle ursolic acid
triple-negative breast cancer
antiproliferative
network pharmacology
molecular docking
Therapeutics. Pharmacology
RM1-950
Yubao Zhang
Xiaoran Ma
Huayao Li
Jing Zhuang
Fubin Feng
Lijuan Liu
Cun Liu
Changgang Sun
Changgang Sun
Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
description Triple negative breast cancer (TNBC) is a subtype of breast cancer with complex heterogeneity, high invasiveness, and long-term poor prognosis. With the development of molecular pathology and molecular genetics, the gene map of TNBC with distinctive biological characteristics has been outlined more clearly. Natural plant extracts such as paclitaxel, vinblastine, colchicine etc., have occupied an important position in the treatment of hormone-independent breast cancer. Ursolic acid (UA), a triterpenoid acid compound derived from apple, pear, loquat leaves, etc., has been reported to be effective in a variety of cancer treatments, but there are few reports on the treatment of TNBC. This study performed comprehensive bioinformatics analysis and in vitro experiments to identify the effect of UA on TNBC treatment and its potential molecular mechanism. Our results showed that UA could not only reduce the proliferation, migration, and invasion in MDA-MB-231 and MDA-MB-468 cell lines with a dose-dependent manner but also induce cell cycle arrest and apoptosis. Meanwhile, we collected the gene expression data GSE45827 and GSE65194 from GEO for comparison between TNBC and normal cell type and obtained 724 DEGs. Subsequently, PLK1 and CCNB1 related to TNBC were screened as the key targets via topological analysis and molecular docking, and gene set enrichment analysis identified the key pathway as the p53 signaling pathway. In addition, quantitative real-time PCR and western blot verified the key genes were PLK1 and CCNB1. In vivo and in vitro experiments showed that UA could inhibit the growth of TNBC cells, and down-regulate the protein expression levels of PLK1 and CCNB1 by mediating p53 signaling pathway. These findings provide strong evidence for UA intervention in TNBC via multi-target therapy.
format article
author Yubao Zhang
Xiaoran Ma
Huayao Li
Jing Zhuang
Fubin Feng
Lijuan Liu
Cun Liu
Changgang Sun
Changgang Sun
author_facet Yubao Zhang
Xiaoran Ma
Huayao Li
Jing Zhuang
Fubin Feng
Lijuan Liu
Cun Liu
Changgang Sun
Changgang Sun
author_sort Yubao Zhang
title Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
title_short Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
title_full Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
title_fullStr Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
title_full_unstemmed Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
title_sort identifying the effect of ursolic acid against triple-negative breast cancer: coupling network pharmacology with experiments verification
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/960a9398b2444583b15a023c2eb9e77d
work_keys_str_mv AT yubaozhang identifyingtheeffectofursolicacidagainsttriplenegativebreastcancercouplingnetworkpharmacologywithexperimentsverification
AT xiaoranma identifyingtheeffectofursolicacidagainsttriplenegativebreastcancercouplingnetworkpharmacologywithexperimentsverification
AT huayaoli identifyingtheeffectofursolicacidagainsttriplenegativebreastcancercouplingnetworkpharmacologywithexperimentsverification
AT jingzhuang identifyingtheeffectofursolicacidagainsttriplenegativebreastcancercouplingnetworkpharmacologywithexperimentsverification
AT fubinfeng identifyingtheeffectofursolicacidagainsttriplenegativebreastcancercouplingnetworkpharmacologywithexperimentsverification
AT lijuanliu identifyingtheeffectofursolicacidagainsttriplenegativebreastcancercouplingnetworkpharmacologywithexperimentsverification
AT cunliu identifyingtheeffectofursolicacidagainsttriplenegativebreastcancercouplingnetworkpharmacologywithexperimentsverification
AT changgangsun identifyingtheeffectofursolicacidagainsttriplenegativebreastcancercouplingnetworkpharmacologywithexperimentsverification
AT changgangsun identifyingtheeffectofursolicacidagainsttriplenegativebreastcancercouplingnetworkpharmacologywithexperimentsverification
_version_ 1718439514582548480